Given the most recent H7N9 outbreak, our company is strategically well positioned to play an integral role in assisting biotech and government efforts to develop new therapies for this potential pandemic threat.
Costa Mesa, California (PRWEB) April 11, 2013
WCCT Global, Full Service CRO, is excited and proud to announce the appointment of Robert Malone, MD, MS as Vice President of Research, Governmental and Scientific Affairs and Medical Director of Virology and Immunotherapeutics.
Dr. Malone is internationally known as an expert in vaccine technology, virology, vaccine production, and clinical development. Dr. Malone holds numerous domestic and foreign patents, and was awarded the initial patents for the discoveries of direct (Naked) DNA delivery, DNA vaccine technologies, and mucosal genetic vaccination. He has published over 30 peer-reviewed publications, organized or served as an invited speaker at numerous national and international conferences, and has served as reviewer or chairperson on more than 15 federal study sections. His extensive research and development experience in the areas of clinical trials, vaccines, gene therapy, bio-defense, and immunology is testament to this well-deserved praise. Dr. Malone is uniquely qualified to bridge innovative new vaccine and immunotherapy discoveries to clinical development, licensure, and commercialization.
Prior to joining WCCT Global Dr. Malone was principal partner with his wife, Jill Glasspool Malone, PhD in their well-known consulting firm which provided innovative solutions for business to business and business to government clinical development projects. Dr. Melton Affrime, Sr. VP, Translational Medicine at WCCT Global, said, “We are pleased to have Robert join our team as we broaden our service offering in the areas of vaccines and government supported anti-infective and bio-defense projects. Given the most recent H7N9 outbreak, our company is strategically well positioned to play an integral role in assisting biotech and government efforts to develop new therapies for this potential pandemic threat."
More about WCCT Global:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
To learn how WCCT Global can benefit your clinical study, CLICK HERE.